Roche Gets Hep C Inhibitor With Potential Twice Daily Dosing From InterMune
Investigational compound ITMN-191 is a candidate for use in combination with Pegasys, Roche says.
Investigational compound ITMN-191 is a candidate for use in combination with Pegasys, Roche says.